English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Zendy Pro

Presents the zaia usage as premium feature

ZAIA

Presents AI Discovery search usage as a premium feature

AI Discovery

Presents AI Discovery explain and summary usage as a premium feature

Content Analysis

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Presents the pdf analysis as premium feature

PDF Analysis

1500 Top-up

3000 Top-up

Zendy Basic

2500 Top-up

Zendy Unlimited

Presents the access of premium content as premium feature

Premium Content

This paper studies the effects that pharmaceutical expenditure and other medical non-durables has on health out¬comes, such as mortality and life expectancy. Some recent research is focused on the study of public expenditure in health and the correlation with positive health indicators, and also on the relative eectiveness of various medical health care inputs. As a specific case of this research, we center our interest on the pharmaceutical expenditure among various European countries in order to compare if expenditures are effective in health results, or on the contrary, countries with higher levels of pharmacy consumption do not have better health indicators. We carried out a regres¬sion analysis with panel data. The results imply that there is a positive effect between pharmaceutical expenditure and health outcomes. Este trabajo estudia los efectos que el gasto farmaceutico y otros articulos medicos de uso frecuente tienen sobre los resultados en salud, en concreto sobre la mortalidad y la esperanza de vida. Algunos trabajos recientes se han cen¬trado en el estudio del gasto publico en salud y su correlacion con indicadores positivos de salud, asi como la efecti¬vidad relativa de varios inputs en salud. Como caso concreto de esta linea de investigacion, este trabajo se centra en el gasto farmaceutico en ciertos paises de la Union Europea, con el fin de comparar si dicho gasto es efectivo en los resultados en salud. La aproximacion metodologica se basa en el analisis de datos de panel. Los resultados corrobo¬ran un efecto positivo entre el gasto y los resultados en salud.

Pharmaceutical Expenditure as a Determinant of Health Outcomes in EU Countries